Mark Merlin

Mark Merlin serves as Medical Director at MedHealth Partners and Chief Medical Officer at Pocket Naloxone Corp. Additionally, Mark holds the position of CEO at MD1Program, the largest Clinical Practice Group of Flight Physicians in the U.S. Mark is also an Adjunct Professor of Emergency Medicine at both the Icahn School of Medicine at Mount Sinai and Rutgers New Jersey Medical School. As a Senior Advisor at Cambridge Consulting Group, Mark provides consulting services to various organizations. Previous roles include Medical Director at TEAM LIFE, INC., Chief Medical Officer at ParaflightEMS focused on organ transplants, and Chair of the NJ EMS Council. Mark has extensive experience with MONOC, serving as Medical Director and Chief Medical Officer for New Jersey's largest EMS system, overseeing a significant number of EMS professionals and equipment.